Federal contract award

75N96018F00002

TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTE OF HEALTH NIEHS
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAZ11 — OTHER RESEARCH AND DEVELOPMENT - BASIC RESEARCH
Parent award / vehicle75N96018D00005
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$20.4M
Current contract value$20.4M
Potential contract value / ceiling$20.4M
Start dateSep 25, 2018
Current end dateJul 22, 2030
Potential end dateJul 22, 2030
Latest award activitySep 23, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 17 of 17 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 23, 2025P00016$2.4MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Jun 23, 2025P00015$5.0KTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Jun 12, 2025P00014$-8.8KTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Mar 6, 2025P00013$0TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Feb 27, 2025P00012$-12.2KTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 13, 2024P00011$3.7MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 10, 2024P00010$59.0KTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Dec 12, 2023P00009$0TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 18, 2023P00008$3.8MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Nov 28, 2022P00007$0TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 20, 2022P00006$4.1MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 14, 2021P00005$1.8MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 3, 2021P00004$0TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY"
Sep 18, 2020P00003$1.3MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"
Mar 24, 2020P00002$222.1KTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"
Sep 19, 2019P00001$1.4MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"
Sep 25, 20180$1.6MTASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"

Estimated positioning window

Jul 22, 2029 – Jan 22, 2030

Recompete signal:
50/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 50/100. Available recorded signals: 45 points.

Contract end 2030-07-22 (1359 days from calculation)
+5 points
4 historical awards in this buyer and category group
+15 points
17 recorded award transactions
+10 points
Latest award action: 2025-09-23
+0 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.